141st APHA Annual Meeting

In This section

284955
Impact of violence-related homicides on life expectancy and years of life lost in Mexico

Tuesday, November 5, 2013

Marguerite L. Sagna, PhD , School of Public Health, University of Alberta, Edmonton, AB, Canada
Miguel Flores, PhD
In recent years, Mexico has experienced unprecedented uprising levels of violence that has been attributed to increasing law enforcement on drug trafficking organization within the country. While the vast majority of this violence has been concentrated in a group of municipalities, particularly in the central Pacific coast and northern Mexico, it has raised very serious concerns on the fact that young adults have been disproportionally exposed to homicide death as compared to other age groups. Using a combination of vital statistics and Census data, the main purpose of this research is to estimate the impact of the upsurge of homicides on life expectancy. Specifically, this study will focus on estimating years of life lost (YLL) by age group, gender, and geographic area. To avoid aggregation issues in the calculations that may result from providing the results at state level, the empirical analysis implies the estimation of life expectancy in small areas considering municipalities as unit of analysis. Thus, municipalities are classified by its quintile distribution resulted from homicides levels during the period 2006-2010.

Learning Areas:
Public health or related public policy
Public health or related research
Social and behavioral sciences

Learning Objectives:
Analyze the effect of homicide on life expectancy; Evaluate years of life lost due to premature death among different demographic groups; Discuss the contribution of homicides to mortality burden in Mexico;

Keywords: Latino, Mortality

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified due to my role as a co-investigator for the study being presented.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.